What is the purpose of treatment for moyamoya disease in pediatric patient?
Best insight from top research papers
The purpose of treatment for moyamoya disease in pediatric patients is to decrease the risk of stroke and improve cerebral hemodynamics. Surgical revascularization is the mainstay of treatment, with indirect procedures such as pial synangiosis being preferred for pediatric patients . Early diagnosis and prompt revascularization surgery are crucial to prevent additional cerebral infarction . Perioperative management based on early hemodynamic study is important to avoid surgical complications, including perioperative cerebral infarction . Surgical revascularization has been shown to decrease the rate of stroke in pediatric patients with moyamoya disease and syndrome . Indirect or combined bypass surgery techniques are commonly used in pediatric patients, as they have been found to provide favorable outcomes . Overall, the goal of treatment for moyamoya disease in pediatric patients is to improve cerebral blood flow and reduce the risk of stroke through surgical revascularization procedures .
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
| The purpose of treatment for moyamoya disease in pediatric patients is to prevent disease progression and reduce the risk of cerebrovascular events. | |
| The purpose of treatment for moyamoya disease in pediatric patients is to decrease ischemic symptoms by using vasodilators and anti-coagulants, and to perform surgical revascularization procedures. | |
06 Sep 2022 | The purpose of treatment for moyamoya disease in pediatric patients is to reduce the risk of future stroke through surgical revascularization. |
| The purpose of treatment for moyamoya disease in pediatric patients is to manage the condition and improve cerebral hemodynamics through surgical revascularization procedures. | |
| The purpose of treatment for moyamoya disease in pediatric patients is to prevent additional cerebral infarction by performing revascularization surgery as early as possible after diagnosis. |
Related Questions
What is the treatment of cavernous hemangioma?4 answersThe treatment of cavernous hemangioma can vary depending on the location and size of the tumor. Surgical excision is a common treatment option for orbital cavernous hemangiomas, especially in cases where there are symptoms, optic nerve compression, or cosmetically disfiguring proptosis. However, gamma knife radiosurgery (GKRS) can be a safe and effective alternative, particularly for patients with optic nerve compression and vision disturbance. Intraosseous hemangiomas, specifically in the maxillary region, are typically treated through surgical resection, with previous embolization to minimize bleeding. For localized vascular lesions, including hemangiomas, various treatment options are available, such as surgery, cryosurgery, electrocoagulation, sclerotherapy, and radiofrequency surgery using coblation. Stereotactic radiosurgery (SRS) and multisession CyberKnife radiosurgery are also viable treatment options for cavernous sinus hemangiomas, particularly for large tumors where resection may be challenging.
What are the advantages and disadvantages of using a PED for treating a ruptured aneurysm?3 answersThe advantages of using a Pipeline embolization device (PED) for treating a ruptured aneurysm include low complication rates, high occlusion rates, and favorable outcomes. The use of PED in ruptured aneurysms is associated with decreased morbidity and mortality compared to open surgical approaches. The PED allows for endovascular repair under local anesthesia, reducing the physiologic stress of avoiding a laparotomy and collateral damage during open repair. However, there are also some disadvantages to consider. The time spent obtaining appropriate imaging and the need for specialized products and personnel for the procedure are potential drawbacks. Additionally, late complications such as abdominal compartment syndrome may occur. Further research, including prospective randomized trials, is needed to provide definitive evidence of the survival advantage of using PED for ruptured aneurysms.
What is prevalence of moyamoya disease?5 answersThe prevalence of moyamoya disease varies depending on the population studied. In the United States, the prevalence of moyamoya in patients with Down syndrome was found to be 0.4%. In a study using US National Inpatient Sample data, the prevalence of psychiatric comorbidities in patients with moyamoya disease was 38.7%. In Kentucky, moyamoya accounted for a substantial number of stroke admissions, with an incidence of 1,983 per 100,000 stroke admissions. In Japan, the incidence and prevalence rates of moyamoya disease are 0.94 and 10.5 patients per 100,000 people, respectively. The prevalence of moyamoya disease is higher in East Asia compared to Western countries, with a peak prevalence at around 10 years and 30-50 years of age.
What is the treatment for carotidynia?4 answersThe treatment for carotidynia involves a combination of nonsteroidal anti-inflammatory drugs (NSAIDs), oral steroids, and pregabalin. Symptomatic treatment with NSAIDs, glucocorticoids, or both can lead to full resolution of symptoms. In some cases, the addition of pregabalin may be necessary for complete symptom relief. It is important to investigate patients to exclude any neurological and/or vascular causes. In rare cases, carotidynia can be induced by medications such as pegfilgrastrim, a granulocyte-colony stimulating factor (G-CSF), and can present with myocarditis and carotidynia. In these cases, treatment with antibiotics, steroids, and supportive care may be necessary. Additionally, carotidynia can be associated with high-altitude traveling, and treatment with low-dose aspirin and NSAIDs can lead to complete resolution of symptoms.
What are the most important unanswered questions regarding the treatment of neurosurgical diseases?5 answersThe most important unanswered questions regarding the treatment of neurosurgical diseases include the need for more effective and safer treatments for neurocysticercosis, as current treatments are suboptimal or based on anecdotal experience. Another important question is the preparation of neurosurgical trainees for making decisions about futility of care, especially in the context of limited resources and the COVID-19 pandemic. Additionally, there is a need for a better understanding of patient selection for surgical therapy in chronic pain management, as successful outcomes depend on appropriate patient selection. Lastly, there is a need for comprehensive guidelines and a diversity of approaches to address the various neurosurgical conditions, as multiple treatment alternatives may be acceptable in real-life situations.
What is the treatment of waardenburg syndrome patients?3 answersThe treatment of Waardenburg syndrome (WS) patients involves a multidisciplinary approach to address the various manifestations of the disorder. Surgical intervention, such as cochlear implantation, may be required to manage sensorineural hearing loss. Anesthetic management during surgical procedures in WS patients can be challenging due to their multisystem abnormalities, and careful planning is necessary to ensure successful outcomes. Specific concerns during anesthesia include difficulties with endotracheal intubation, tracheal involvement, impaired communication related to deafness, and associated congenital heart disease. Additionally, WS patients may require treatment for associated conditions, such as dry eyes, which can be managed with proper refractive correction and appropriate dry eye therapy. Overall, a comprehensive approach that addresses the specific needs of each patient is essential for the management of Waardenburg syndrome.